The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Olivier Mueller

Showing 1-14 of 14 articles
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial
Iglesias JF, Mueller O, Zaugg S, Roffi M, Kurz D, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeckhout E, Jüni P, Windecker S, Pilgrim T
August 24, 2018 | 10.4244/EIJ-D-17-00734
Interventions for valvular disease
Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses
Seiffert M, Treede H, Schofer J, Linke A, Wöhrle J, Baumbach H, Mehilli J, Bapat V, Simonato M, Walther T, Kullmer M, Boekstegers P, Ensminger S, Kurz T, Eltchaninoff H, Rastan A, Werner N, de Weger A, Frerker C, Lauer B, Mueller O, Whisenant B, Thukkani A, Weisz G, Dvir D
July 20, 2018 | 10.4244/EIJ-D-17-00546
Interventions for valvular disease
How should I treat an Edwards SAPIEN 3 aortic valve embolisation during a transaortic transcatheter aortic valve implantation?
Fournier S, Monney P, Roguelov C, Ferrari E, Eeckhout E, Mueller O, Durko A, Van Mieghem N, Kappetein AP, Margey R
July 20, 2017 | 10.4244/EIJ-D-16-00592
Coronary interventions
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Mueller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S
December 9, 2016 | 10.4244/EIJY15M12_09
Coronary interventions
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial
Franzone A, Taniwaki M, Rigamonti F, Heg D, Piccolo R, Roffi M, Tüller D, Mueller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Jüni P, Windecker S, Pilgrim T
August 5, 2016 | 10.4244/EIJV12I5A99
Coronary interventions
How should I treat a coronary artery fistula complicated with myocarditis – PCI or surgery?
Morawiec B, Mueller O, Khatchatourov G, Goy J-J, Qureshi S, Silaschi M, Wendler O
June 10, 2016 | 10.4244/EIJV12I2A45
Tools & Techniques: The year of the textbook – time to say good-bye!
Naber C, Sachdev B, Mueller O, Eeckhout E, Fajadet J
May 15, 2012 | 10.4244/EIJV8I1A24
AsiaPCR/SingLive: in its third year and growing
Lim E, Lim C, Mueller O, Yeo KK, Lim S-T, Koh T-H, Eeckhout E
February 21, 2012 | 10.4244/EIJV7I10A184
Complications with a happy ending
Mueller O, Lerman A, Eeckhout E
December 30, 2011 | 10.4244/EIJV7I8A141
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study
Puricel S, Adorjan P, Oberhänsli M, Stauffer J-C, Moschovitis A, Vogel R, Goy J-J, Mueller O, Eeckhout E, Togni M, Wenaweser P, Meier B, Windecker S, Cook S
October 28, 2011 | 10.4244/EIJV7I6A112
Transcriptional fingerprint of human whole blood at the site of coronary occlusion in acute myocardial infarction
Mueller O, Delrue L, Hamilos M, Vercauteren S, Ntalianis A, Trana C, Mangiacapra F, Dierickx K, De Bruyne B, Wijns W, Behfar A, Barbato E, Terzic A, Vanderheyden M, Bartunek J
August 30, 2011 | 10.4244/EIJV7I4A75
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update
Cuisset T, Valgimigli M, Mudra H, Mueller O, Wijns W, Huber K
May 25, 2010
Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations
Mueller O, Windecker S, Cuisset T, Fajadet J, Mason M, Zuffi A, Doganov A, Eeckhout E
August 20, 2008
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions
Cuisset T, Mudra H, Mueller O, Vogt P, Angelillo-Scherrer A, Huber K
August 20, 2008

Latest news

NEW ISSUE
Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…
Tetralogy of Fallot with acquired double right ventricular outflow tract
September 18, 2020
NEW
Ahead of print: Leaflex Study
September 23, 2020
Editorial
Integrating physiology in OCT
Gianluca Campo
September 23, 2020
PCR Trials
BioFlow IV, TWILIGHT, Evolut Low Risk and many others
(Released thanks to the support of Biotronik)
September 25, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Steady-state hyperaemia
G.G. Toth
September 18, 2020
JAA
This Week's JAA's: Impact of neoatherosclerosis in ISR on clinical outcome...
September 29, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke